Yaiza Rosales Salgado

Preclinical efficacy, safety, and immunogenicity of a COVID-19 vaccine candidate based on a recombinant RBD fusion heterodimer of SARS-CoV-2

J. Barretina, B. Clotet, J. Segalés, 2022 .

Preclinical efficacy, safety, and immunogenicity of PHH-1V, a second-generation COVID-19 vaccine candidate based on a novel recombinant RBD fusion heterodimer of SARS-CoV-2

J. Barretina, B. Clotet, J. Segalés, 2021 .

Preclinical evaluation of a COVID-19 vaccine candidate based on a recombinant RBD fusion heterodimer of SARS-CoV-2

J. Barretina, B. Clotet, J. Segalés, 2021, bioRxiv.